Skip to main content

Recommended

Services

    PI Leaflets

      Pages

        No results found.

        News stories

        New kit aims to improve liver care and cut waiting times

        Published on 04/08/2025

        Mr Nasir Mir, Consultant Gatroenterologist (left) and Mr Monzur Ahmed, Consultant Gastroenterologist (right) with the fibroscan
        Mr Nasir Mir, Consultant Gatroenterologist (left) and Mr Monzur Ahmed, Consultant Gastroenterologist (right) with the fibroscan

        Patients at Good Hope Hospital can now receive faster and more efficient liver assessments, with the introduction of a new fibroscan machine.

        A fibroscan is a type of ultrasound to measure inflammation in your liver. It helps your doctor to understand how much scarring (fibrosis) is in your liver and plan your treatment. The device is especially useful in diagnosing and monitoring chronic liver diseases such as hepatitis, fatty liver disease, and cirrhosis.

        The non-invasive device enables consultants to assess liver health during a patient’s first outpatient appointment, streamlining care and significantly reducing waiting times.

        Previously, liver referrals at Good Hope Hospital required multiple appointments. A patient would first see a gastroenterology or hepatology consultant, and if further investigation was needed, they would be referred to Heartlands Hospital for a fibroscan. This meant returning for a third follow-up appointment to discuss the results; an inconvenient process for patients.

        Now, when patients come in for their initial consultation, clinicians can perform the diagnostic scan immediately and often reach a conclusion in the same visit.

        The new setup also means fewer follow-up appointments, which not only benefits patients but helps reduce waiting lists.

        The fibroscan assesses liver stiffness and fat content and offers a non-invasive alternative to traditional liver biopsies. Like an ultrasound scan for a baby, it uses ultrasound-based technology to detect signs of liver disease, without the need for invasive procedures or lab histology.

        Many patients who would otherwise need a biopsy can now avoid that process altogether.

        Between March and June this year, over 100 patients have benefitted from being able to undergo the procedure closer to home.

        Mr Nasir Mir, Gastroenterology Consultant, said: “Liver disease is indeed a significant health challenge in UK, and having an effective tool like fibroscan at Good Hope Hospital is crucial in managing and screening our patients.

        “This will remain an effective tool to optimise our care and service development by early detection and prompt intervention to improve outcomes.”

        More news

        Celebrating 25 years of the NIHR Birmingham Clinical Research Facility

        Celebrating 25 years of the NIHR Birmingham Clinical Research Facility

        This year, we are celebrating 25 years of the National Institute for Health and Care Research (NIHR) Birmingham Clinical Research Facility (CRF) at Queen Elizabeth Hospital Birmingham (QEHB). The milestone was marked with a special anniversary event, bringing together current and former colleagues who have played a role in the CRF's success over the years.
        Heartlands conference puts research at the heart of tackling health inequalities

        Heartlands conference puts research at the heart of tackling health inequalities

        The first two-day Heartlands Research and Quality Improvement Conference has been hailed a success. More than 200 colleagues came together at the start of October to celebrate and share research and quality improvement projects that are taking place at Heartlands Hospital.
        National fellowship marks major step for early-phase dementia research in Birmingham

        National fellowship marks major step for early-phase dementia research in Birmingham

        University Hospitals Birmingham (UHB) is set to strengthen its role in dementia research following the award of a prestigious UK Dementia Trials Network (UKDTN) Clinical Trials Fellowship to consultant neurologist Dr Will Scotton.
        Read more news